[HTML][HTML] Polyphenols and their potential role to fight viral diseases: An overview

MF Montenegro-Landívar, P Tapia-Quirós… - Science of the Total …, 2021 - Elsevier
Fruits, vegetables, spices, and herbs are a potential source of phenolic acids and
polyphenols. These compounds are known as natural by-products or secondary metabolites …

Coronavirus helicases: Attractive and unique targets of antiviral drug-development and therapeutic patents

AN Spratt, F Gallazzi, TP Quinn, CL Lorson… - Expert opinion on …, 2021 - Taylor & Francis
Introduction: Coronaviruses encode a helicase that is essential for viral replication and
represents an excellent antiviral target. However, only a few coronavirus helicase inhibitors …

Human immunodeficiency virus drug resistance: 2018 recommendations of the International Antiviral Society–USA Panel

HF Günthard, V Calvez, R Paredes… - Clinical Infectious …, 2019 - academic.oup.com
Background Contemporary antiretroviral therapies (ART) and management strategies have
diminished both human immunodeficiency virus (HIV) treatment failure and the acquired …

Cohort profile: InfCareHIV, a prospective registry-based cohort study of people with diagnosed HIV in Sweden

C Carlander, J Brännström, F Månsson, O Elvstam… - BMJ open, 2023 - bmjopen.bmj.com
Purpose The Swedish InfCareHIV cohort was established in 2003 to ensure equal and
effective care of people living with HIV (PLHIV) and enable long-term follow-up. InfCareHIV …

[HTML][HTML] Nose to brain delivery of antiretroviral drugs in the treatment of neuroAIDS

A Sarma, MK Das - Molecular biomedicine, 2020 - Springer
Abstract NeuroAIDS (Neuro Acquired Immunodeficiency Syndrome) or HIV (Human
Immunodeficiency Virus) associated neuronal abnormality is continuing to be a significant …

Ex-vivo antiretroviral potency of newer integrase strand transfer inhibitors cabotegravir and bictegravir in HIV type 1 non-B subtypes

U Neogi, K Singh, SG Aralaguppe, LC Rogers… - Aids, 2018 - journals.lww.com
Objective: To determine the antiretroviral activity of the integrase strand transfer inhibitors
(INSTIs), raltegravir (RAL), elvitegravir (EVG), dolutegravir (DTG), cabotegravir (CAB) and …

[HTML][HTML] Analyses of HIV-1 integrase sequences prior to South African national HIV-treatment program and availability of integrase inhibitors in Cape Town, South …

D Brado, AE Obasa, GM Ikomey, R Cloete, K Singh… - Scientific reports, 2018 - nature.com
HIV-Integrase (IN) has proven to be a viable target for highly specific HIV-1 therapy. We
aimed to characterize the HIV-1 IN gene in a South African context and identify resistance …

[HTML][HTML] Molecular dynamic simulations to investigate the structural impact of known drug resistance mutations on HIV-1C Integrase-Dolutegravir binding

R Chitongo, AE Obasa, SG Mikasi, GB Jacobs… - PLoS …, 2020 - journals.plos.org
Resistance associated mutations (RAMs) threaten the long-term success of combination
antiretroviral therapy (cART) outcomes for HIV-1 treatment. HIV-1 Integrase (IN) strand …

Virologic outcomes in early antiretroviral treatment: HPTN 052

SH Eshleman, EA Wilson, XC Zhang, SS Ou… - HIV clinical …, 2017 - Taylor & Francis
Introduction: The HIV Prevention Trials Network (HPTN) 052 trial demonstrated that early
antiretroviral therapy (ART) prevented 93% of HIV transmission events in serodiscordant …

[HTML][HTML] Structural implications of genotypic variations in HIV-1 integrase from diverse subtypes

L Rogers, AE Obasa, GB Jacobs… - Frontiers in …, 2018 - frontiersin.org
Human immunodeficiency virus type 1 (HIV-1) integrase (IN) integrates viral DNA into the
host genome using its 3′-end processing and strand-transfer activities. Due to the …